Example: Heart Attack

Search clinical trials for: Pilocarpine

Total 39 results

NCT04503252

Recruiting

Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus

Conditions: Complicated S. Aureus Infection (CSAI)
NCT04470479

Completed

Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome

Conditions: Dry Eye
NCT04195100

Completed

Local Pilocarpine for Relieving Dry Mouth

Conditions: Patients of Advanced Age (≥ 70 Years) With a Clinical Diagnosis of Chronic Dry Mouth
NCT04085094

Recruiting

Gender Differences in Renal Functioning and Disease

Conditions: Chronic Renal Failure; Healthy Controls
NCT04005079

Suspended

Pilocarpine After Combined Cataract/Trabectome Surgery

Conditions: Open Angle Glaucoma; Ocular Hypertension
NCT03933631

Enrolling by invitation

Pilocarpine Use After Kahook Goniotomy

Conditions: Glaucoma
NCT03825081

Recruiting

Pilocarpine and Brimonidine in Patients With Monofocal Lenses

Conditions: Presbyopia; Pseudophakia
NCT03798223

Enrolling by invitation

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

Conditions: Glaucoma, Open-Angle; Pseudoexfoliation Glaucoma; Ocular Hypertension
NCT03753009

Completed

Iontophoretic Transepithelial Collagen Cross-linking Versus Epithelium-off Collagen Cross-linking in Pediatric Patients. Three Year Follow up.

Conditions: Keratoconus
NCT03584841

Recruiting

Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test

Conditions: Mucoviscidosis Involving the Lung
NCT03460964

Terminated

Measuring Sweat Glucose of Patients With Diabetes - The ENGAGE Study

Conditions: Diabetes Mellitus
NCT02982577

Unknown status

Effect of Pilocarpine in Patients With Xerostomia

Conditions: Xerostomia
NCT02935894

Completed

Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat

Conditions: Stability & Variability of Lipid-derived Molecules in Sweat
NCT02865473

Recruiting

Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study

Conditions: Glaucoma
NCT02754570

Completed

The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure

Conditions: Glaucoma, Open-angle; Hypertension, Ocular
NCT02613013

Recruiting

Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure

Conditions: Glaucoma, Angle-Closure
NCT02485067

Completed

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

Conditions: Overactive Bladder
NCT02447315

Completed

A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects

Conditions: Healthy Subjects
NCT02420782

Completed

First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology

Conditions: Healthy Volunteers
NCT02310789

Completed

(Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?

Conditions: Cystic Fibrosis
NCT02279472

Unknown status

Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy

Conditions: Primary Angle Closure Glaucoma
NCT01690052

Completed

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva

Conditions: Dry Mouth
NCT01627626

Completed

Effect of 0.1% Pilocarpine Mouthwash on Xerostomia

Conditions: Xerostomia
NCT01126203

Completed

Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension

Conditions: Exfoliation Syndrome; Ocular Hypertension
NCT01036035

Completed

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Conditions: Incontinence
NCT00803803

Completed

Dose, Effects and Characteristics of Pilocarpine

Conditions: Open-angle Glaucoma
NCT00804115

Unknown status

The International Collaborative Exfoliation Syndrome Treatment Study

Conditions: Exfoliation Syndrome; Glaucoma; Ocular Hypertension
NCT00762645

Completed

Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)

Conditions: Angle-Closure Glaucoma
NCT00656513

Completed

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Conditions: Head and Neck Cancer; Xerostomia
NCT00624039

Unknown status

The Effect of Cataract Extraction on the Contractility of Ciliary Muscle

Conditions: Presbyopia; Cataract
NCT00618059

Completed

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

Conditions: Dry Mouth
NCT00601211

Completed

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions

Conditions: Dry Mouth
NCT00601874

Completed

Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions

Conditions: Dry Mouth
NCT00602524

Completed

Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions

Conditions: Dry Mouth
NCT00438048

Completed

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

Conditions: Primary Sjogren; Secondary Sjogren; Xerostomia
NCT00343382

Completed

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

Conditions: Breast Cancer; Vaginal Dryness
NCT00168181

Completed

Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients

Conditions: Cancer; Head and Neck Cancer
NCT00003139

Completed

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Conditions: Head and Neck Cancer; Oral Complications
NCT00003686

Terminated

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

Conditions: Oral Complications; Quality of Life